Rebecca Abraham (Courtesy photo)
Acute on Chronic is one of many cannabis ancillary businesses that stand to benefit if the U.S. Drug Enforcement Administration moves to reschedule marijuana.
The Chicago-based company has two physicians and several registered nurses who assist patients nationwide with product selection, dosage and obtaining medical marijuana cards.
“We’ve been preparing for this because we knew the problem already existed,” Rebecca Abraham, founder and CEO of Acute on Chronic, said about the prospect of marijuana being moved from Schedule 1 to Schedule 3 of the Controlled Substances Act.
“Patients need guidance; we need more science, more information.”
ADVERTISEMENT
Days after the U.S. Department of Health and Human Services released an unredacted version of its recommendation that the DEA reschedule marijuana –
Read full article on Marijuana Business Daily
